Salarius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor.
CEODavid J. Arthur
CEODavid J. Arthur
Employees2
Employees2
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2014
Founded2014
Employees2
Employees2
SLRX Key Statistics
Market cap1.35M
Market cap1.35M
Price-Earnings ratio-0.12
Price-Earnings ratio-0.12
Dividend yield—
Dividend yield—
Average volume286.18K
Average volume286.18K
High today$0.6498
High today$0.6498
Low today$0.61
Low today$0.61
Open price$0.61
Open price$0.61
Volume121.77K
Volume121.77K
52 Week high$7.20
52 Week high$7.20
52 Week low$0.4519
52 Week low$0.4519
People also own
Based on the portfolios of people who own SLRX. This list is generated using Robinhood data, and it’s not a recommendation.